Sign in
4

Changes in Ownership

FENNEC PHARMACEUTICALS INC. Filed Acc 0001926254-26-000008

Chief Executive Officer acquired 1,159 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hackman Jeffrey S. Chief Executive Officer 2026-05-31 Grant or award +1,159 62,825 D: show line 1 in the form
Loading xslF345X06/form4-06012026_040603.xml…